KENIG and coworkers4, 5) found that IV is transported into cells of E. coli B and Staphylococcus aureus via the dipeptide transport system (dpp).
Anticapsin, the C-terminal amino acid of IV, is a very poor antimicrobial agents5) but is a powerful inhibitor of glucosamine synthetase in extracts of S. aureus.
It was suggested that the antibacterial activity of IV depends on its transport into the organism, on its hydrolysis to anticapsin, and on inhibition of glucosamine synthetase by the latter4).
The synthetic anti- Table 1 . Antagonism tests with inhibitors III, IV, V, VI, and VII and various peptides.
Test strains E. coli K-12 wild type (wt; opp+ dpp+) and mutant A (opp-dpp+).
Assay method: antagonism test according to ZAHNER and coworkers14); medium: DAVIS & MIN-GIOLI'S minimal medium15) with the addition of 15 g/liter agar; concentration of the peptides: 10 mM; (+), reversion of inhibition; (-), no reversion; (n.t.), not tested. pret the competition with tri-L-methionine either as a reversion of the action at the level of the target, or as an antagonism at the binding site of a specific peptide permease. 
